Continually Updated Clinical Reference
 
 
  All Sources     eMedicine     Medscape     Drug Reference     MEDLINE
 
You are in: eMedicine Specialties > Emergency Medicine > Infectious Diseases

Breast Abscess and Masses

Last Updated: October 27, 2005
Email to a Colleague
Synonyms and related keywords: breast mass, breast abscess, malignant breast disease, benign breast mass, malignant breast mass, breast lump, breast cancer, mastitis, postpartum mastitis, in situ lobular or ductal cancer, intraductal papilloma, infiltrating ductal carcinoma, inflammatory carcinoma, fibroadenoma

  AUTHOR INFORMATION Section 1 of 10    Click here to go to the next section in this topic
Author Information Introduction Clinical Differentials Workup Treatment Medication Follow-up Miscellaneous Bibliography

Author: Howard A Blumstein, MD, FAAEM, Assistant Professor, Surgery; Medical Director, Department of Emergency Medicine, Wake Forest University School of Medicine

Coauthor(s): Amy K Rontal, MD, Clinical Instructor, Department of Emergency Medicine, University of Michigan Health System

Howard A Blumstein, MD, FAAEM, is a member of the following medical societies: American Academy of Emergency Medicine, American College of Emergency Physicians, American Medical Association, Emergency Medicine Residents' Association, and Society for Academic Emergency Medicine

Editor(s): David FM Brown, MD, Assistant Professor, Department of Medicine, Division of Emergency Medicine, Harvard Medical School; Vice-Chair, Department of Emergency Medicine, Massachusetts General Hospital; Francisco Talavera, PharmD, PhD, Senior Pharmacy Editor, eMedicine; Barry J Sheridan, DO, Chief, Department of Emergency Medical Services, Brooke Army Medical Center; John Halamka, MD, Chief Information Officer, CareGroup Healthcare System, Assistant Professor of Medicine, Department of Emergency Medicine, Beth Israel Deaconess Medical Center; Assistant Professor of Medicine, Harvard Medical School; and Jonathan Adler, MD, Attending Physician, Department of Emergency Medicine, Massachusetts General Hospital; Division of Emergency Medicine, Harvard Medical School

Disclosure


  INTRODUCTION Section 2 of 10   Click here to go to the previous section in this topic Click here to go to the top of this page Click here to go to the next section in this topic
Author Information Introduction Clinical Differentials Workup Treatment Medication Follow-up Miscellaneous Bibliography

Background: Patients typically do not present in the ED with a breast mass as their chief complaint; however, knowledge of the pertinent anatomy, pathophysiology, and clinical clues is essential.

Breast masses can be broadly classified as benign or malignant. Common causes of benign breast masses include fibrocystic disease, fibroadenoma, and abscess. Malignant breast disease encompasses many histologic types that include, but are not limited to, in situ lobular or ductal cancer, intraductal papilloma, infiltrating ductal carcinoma, and inflammatory carcinoma. The main concern of many women presenting with a breast mass is the likelihood of cancer; however, most breast masses are benign.

Pathophysiology: Breast masses can involve any of the tissues that make up the breast, including overlying skin, ducts, lobules, and connective tissues. Fibrocystic disease, the most common breast mass in women, is found in 60-90% of breasts during routine autopsy. Fibroadenoma, the most common benign tumor, typically affects women younger than 30 years. Infiltrating ductal carcinoma is the most common malignant tumor. Inflammatory carcinoma is the most aggressive malignant tumor and carries the worst prognosis.

The breast is a modified sweat gland with multiple secretory acini that drain into lactiferous ducts. These ducts are grouped into lobules, which are demarcated by Cooper ligaments. Each of the lobule secretory ducts converge to form one ampulla, which traverses the nipple to open at the apex. When the lactiferous duct lining undergoes epidermalization, keratin production can cause plugging of the duct and result in abscess formation. This helps explain the high recurrence rate (an estimated 39-50%) of breast abscesses in patients treated with standard incision and drainage (I&D). This technique does not address the basic mechanism by which breast abscesses are thought to occur.

Postpartum mastitis is a localized cellulitis caused by bacterial invasion through an irritated or fissured nipple. It typically occurs after the second postpartum week and is precipitated by milk stasis.

Frequency:

  • In the US: One out of every 8 women is diagnosed with breast cancer during her lifetime. Breast abscess is more common in nonlactating (nonpuerperal) women than in women who are lactating. One study found that, over a 10-year period, 8.5% of 72 women presenting with a breast abscess were in puerperium. Postpartum mastitis occurs in 1-5% of lactating women.

Mortality/Morbidity:

  • Breast mass: Morbidity and mortality depends on pathology of the mass. Approximately 1 in 28 (3.6%) women die from breast cancer. Associated morbidity may include scarring, disfigurement, and lymphedema.
  • Breast abscess: Recurrent or chronic infections, pain, and scarring are causes of morbidity.
  • Mastitis: Abscess formation is a complication of postpartum mastitis in fewer than 10% of individuals affected.

Race: Premenopausal breast cancer is more likely to develop in black women than white women. This is not true during the postmenopausal period.

Sex: Breast masses are overwhelmingly a disease of women.

Age: Women older than 40 years account for more than 80% of breast cancer patients. The median age of diagnosis is 64 years.

  • Nonpuerperal breast masses encompass the third to eighth decades of life.
  • Puerperal breast abscesses and mastitis are commonly found in women of childbearing age.
  • Fibroadenoma is the most common cause of breast mass in women up to age 35 years.


  CLINICAL Section 3 of 10   Click here to go to the previous section in this topic Click here to go to the top of this page Click here to go to the next section in this topic
Author Information Introduction Clinical Differentials Workup Treatment Medication Follow-up Miscellaneous Bibliography

History:

  • Breast mass
    • Palpable mass, typically only in one breast
    • Family history of breast disease, malignant and benign
    • Menstrual and obstetrical histories
    • Associated symptoms of pain, nipple discharge, and skin changes (eg, dimpling or inflammation, nipple inversion)
    • Length of time present, speed of growth
    • No history at all if the mass is found during physical examination
  • Breast abscess
    • Localized breast area edematous, erythematous, warm, and painful
    • History of previous breast abscess
    • Associated symptoms of fever, vomiting, and spontaneous drainage from the mass or nipple
    • May be lactating
  • Mastitis
    • Localized breast area erythematous, warm, and painful
    • May have fever and chills
    • May be lactating and may have recently missed feedings

Physical: Perform a thorough breast examination for any patient presenting with a breast complaint and any older woman presenting with unexplained weight loss, anorexia, or bone pain. Talk through the examination, giving extra instruction on how and when patients can perform breast self-examination at home.

  • Breast mass
    • Firm mass of variable shape and size
    • Fifty percent of masses found in the upper outer quadrant of the breast
    • May have associated pain with palpation, but most are painless
    • Nipple discharge
    • Skin retraction or tethering
    • Axillary lymphadenopathy
    • Inflammatory changes of the skin (ie, peau d'orange)
  • Breast abscess
    • Localized breast area erythematous, hot, edematous, and extremely painful
    • Most commonly found in the areolar or periareolar area
    • Fluctuance of the mass
    • May have associated fever or axillary lymphadenopathy
    • Discharge with palpation from nipple or mass
    • Nipple inversion
  • Mastitis
    • Localized breast area erythematous, warm, indurated, and tender
    • May have associated fever

Causes:

  • Breast mass
    • Risk factors for breast cancer include female sex, age older than 40 years, family history of breast cancer, nulliparity, menarche before age 12, menopause after age 55, and late pregnancy.
    • The BRCA gene is responsible for 5% of all breast cancers and is inherited in an autosomal dominant fashion. Of those with the gene, 60% develop breast cancer by age 50 years.
  • Breast abscess
    • Staphylococcus aureus and streptococcal species are the most common organisms isolated in puerperal breast abscesses. Nonpuerperal abscesses typically contain mixed flora (S aureus, streptococcal species) and anaerobes.
    • A study by Schafer et al found a significant correlation between cigarette smoking and subareolar breast abscess.
  • Mastitis
    • S aureus is most common cause, typically originating from the nursing child. Streptococci, enterococci, Staphylococcus epidermidis, and Escherichia coli are less common.
  DIFFERENTIALS Section 4 of 10   Click here to go to the previous section in this topic Click here to go to the top of this page Click here to go to the next section in this topic
Author Information Introduction Clinical Differentials Workup Treatment Medication Follow-up Miscellaneous Bibliography

Cellulitis


Other Problems to be Considered:

Breast cancer
Fibroadenoma
Fibrocystic disease
Fat necrosis
Mastitis


Breast Cancer Resource Center
Breast Cancer Resource Center

View all Breast Cancer Articles

Breast Cancer Multimedia Library


Quick Find
Author Information
Introduction
Clinical
Differentials
Workup
Treatment
Medication
Follow-up
Miscellaneous
Bibliography

Click for related images.

Related Articles
Cellulitis


Patient Education



  WORKUP Section 5 of 10   Click here to go to the previous section in this topic Click here to go to the top of this page Click here to go to the next section in this topic
Author Information Introduction Clinical Differentials Workup Treatment Medication Follow-up Miscellaneous Bibliography

Lab Studies:

  • In patients suspected of having a breast abscess, a CBC with differential can be helpful. An aerobic and anaerobic culture may be taken in the operating room.

Imaging Studies:

  • Perform ultrasonography to determine solid versus cystic structures in the breast and to direct needle aspiration for abscess drainage.
  • Schedule a mammography (criterion standard for breast mass evaluation) as an outpatient study to further define the suspected breast mass.

Procedures:

  • Some argue that needle aspiration of a breast abscess is a successful method of treatment. However, this procedure is probably best left to a surgeon because multiple aspirations over time are necessary for complete resolution.
  • For many years, I&D has been the standard of care for abscesses. However, simple I&D does not treat the underlying cause of the breast abscess, and it may result in a high number of recurrences.
  TREATMENT Section 6 of 10   Click here to go to the previous section in this topic Click here to go to the top of this page Click here to go to the next section in this topic
Author Information Introduction Clinical Differentials Workup Treatment Medication Follow-up Miscellaneous Bibliography

Emergency Department Care:

  • Breast mass
    • Definitive diagnosis of the etiology can only be made by pathologic examination and is not an emergency. Timely follow-up care, including mammography and involvement of primary physician and surgeon, is essential.
    • Finding a breast mass can be stressful for patients; provide reassurance that not all breast masses are malignant.
  • Breast abscess: Identify the problem and provide pain control, antibiotic therapy, and prompt surgical consultation.
  • Mastitis: Treat with antistaphylococcal antibiotics, warm compresses, and continued emptying of the breast by breastfeeding or breast pumping.

Consultations:

  • Patients with breast masses need to be seen by a general surgeon for definitive treatment. Immediate consultation in the ED is not mandatory, but it may help facilitate faster follow-up care once patients are discharged from the hospital.
  • Patients with suspected breast abscess should be seen by a surgeon for definitive care.

  MEDICATION Section 7 of 10   Click here to go to the previous section in this topic Click here to go to the top of this page Click here to go to the next section in this topic
Author Information Introduction Clinical Differentials Workup Treatment Medication Follow-up Miscellaneous Bibliography

The goal of therapy is to eradicate the infection and minimize complications.

Drug Category: Antibiotics -- Therapy must cover all likely pathogens in the context of the clinical setting.
Drug Name
Nafcillin (Unipen) -- DOC for puerperal breast abscess. Treats infections caused by penicillinase-producing staphylococci. Used to initiate therapy when a penicillin G–resistant staphylococcal infection is suspected.
Because of occasional occurrence of thrombophlebitis associated with parenteral route (particularly in elderly persons), administer parenterally only for a short term (24-48 h) and change to PO if clinically possible.
Adult Dose2 g IV q4h
Pediatric Dose150 mg/kg/d IV divided q6h
ContraindicationsDocumented hypersensitivity
Interactions Associated with warfarin resistance when administered concurrently; effects may decrease with bacteriostatic action of tetracycline derivatives
Pregnancy B - Usually safe but benefits must outweigh the risks.
PrecautionsTo optimize therapy, determine causative organisms and susceptibility; >10 d treatment to eliminate infection and prevent sequelae (eg, endocarditis, rheumatic fever); take cultures after treatment to confirm that infection is eradicated
Drug Name
Vancomycin (Vancocin, Vancoled, Lymphocin) -- DOC for patients with puerperal breast abscess who are penicillin allergic. Potent antibiotic directed against gram-positive organisms and active against enterococcal species. Useful in treatment of septicemia and skin structure infections. Indicated for patients who cannot receive, or have failed to respond to, penicillins and cephalosporins or who have infections with resistant staphylococci.
To avoid toxicity, current recommendation is to assay vancomycin trough levels after the third dose drawn 0.5 h before next dosing. Use CrCl to adjust dose in renal impairment, prn.
Adult Dose1 g IV q12h
Pediatric Dose40 mg/kg IV tid/qid
ContraindicationsDocumented hypersensitivity
InteractionsErythema, histaminelike flushing and anaphylactic reactions may occur when administered with anesthetic agents; taken concurrently with aminoglycosides, risk of nephrotoxicity may increase above that with aminoglycoside monotherapy; effects in neuromuscular blockade may be enhanced when coadministered with nondepolarizing muscle relaxants
Pregnancy C - Safety for use during pregnancy has not been established.
PrecautionsCaution in renal failure and neutropenia; red man syndrome is caused by too rapid IV infusion (dose administered over a few minutes) but rarely happens when dose given as 2-hour administration or as PO or IP administration; red man syndrome is not an allergic reaction
Drug Name
Clindamycin (Cleocin) -- DOC for nonpuerperal breast abscess. An alternate DOC for patients with mastitis who are penicillin allergic.
A lincosamide useful as treatment against serious skin and soft tissue infections caused by most staphylococcal strains. Also effective against aerobic and anaerobic streptococci, except enterococci.
Inhibits bacterial protein synthesis by inhibiting peptide chain initiation at the bacterial ribosome where it preferentially binds to the 50S ribosomal subunit, causing bacterial growth inhibition.
Adult Dose300 mg IV/PO q6h
Pediatric Dose20-40 mg/kg IV/IM tid/qid
ContraindicationsDocumented hypersensitivity; regional enteritis, ulcerative colitis, hepatic impairment, antibiotic-associated colitis
InteractionsIncreases duration of neuromuscular blockade, induced by tubocurarine and pancuronium; erythromycin may antagonize effects; antidiarrheals may delay absorption
Pregnancy B - Usually safe but benefits must outweigh the risks.
PrecautionsAdjust dose in severe hepatic dysfunction; no adjustment necessary in renal insufficiency; associated with severe and possibly fatal colitis
Drug Name
Ampicillin-sulbactam sodium (Unasyn) -- Alternative DOC for nonpuerperal breast abscess. Drug combination that utilizes a beta-lactamase inhibitor with ampicillin. Covers skin, enteric flora, and anaerobes. Not ideal for nosocomial pathogens.
Adult Dose1.5 (1 g ampicillin + 0.5 g sulbactam) to 3 g (2 g ampicillin + 1 g sulbactam) IV/IM q6-8h; not to exceed 4 g/d sulbactam or 8 g/d ampicillin
Pediatric Dose3 months to 12 years: 100-200 mg ampicillin/kg/d (150-300 mg Unasyn) IV divided q6h
>12 years: Administer as in adults; not to exceed 4 g/d sulbactam or 8 g/d ampicillin
ContraindicationsDocumented hypersensitivity
InteractionsProbenecid and disulfiram elevate ampicillin levels; allopurinol decreases ampicillin effects and has additive effects on ampicillin rash; may decrease effects of oral contraceptives
Pregnancy B - Usually safe but benefits must outweigh the risks.
PrecautionsAdjust dose in renal failure; evaluate rash and differentiate from hypersensitivity reaction
Drug Name
Dicloxacillin (Dycill, Dynapen) -- DOC for mastitis. Bactericidal antibiotic that inhibits cell wall synthesis. Used to treat infections caused by penicillinase-producing staphylococci. May be used to initiate therapy when a staphylococcal infection is suspected.
Adult Dose500 mg PO qid
Pediatric Dose12-25 mg/kg/d PO divided qid
ContraindicationsDocumented hypersensitivity
InteractionsDecreases efficacy of oral contraceptives; increases effects of anticoagulants; probenecid and disulfiram may increase penicillin levels
Pregnancy B - Usually safe but benefits must outweigh the risks.
PrecautionsMonitor PT in patients taking anticoagulant medications; toxicity may increase in renal impairment
Drug Name
Oxacillin (Bactocill, Prostaphlin) -- Bactericidal antibiotic that inhibits cell wall synthesis. Used in the treatment of infections caused by penicillinase-producing staphylococci. May be used to initiate therapy when a staphylococcal infection is suspected.
Adult Dose500-1000 mg PO q4-6h
150-200 mg/kg/d IM/IV divided q6h
Pediatric Dose50-100 mg/kg/d PO divided q6h
150-200 mg/kg/d IM/IV divided q6h; not to exceed 12 g/d
ContraindicationsDocumented hypersensitivity
InteractionsOxacillin decreases effects of contraceptives and tetracycline; administered concomitantly with disulfiram and probenecid, may increase oxacillin levels; effect of anticoagulants increase with large IV doses of oxacillin
Pregnancy B - Usually safe but benefits must outweigh the risks.
PrecautionsCaution in impaired renal function
  FOLLOW-UP Section 8 of 10   Click here to go to the previous section in this topic Click here to go to the top of this page Click here to go to the next section in this topic
Author Information Introduction Clinical Differentials Workup Treatment Medication Follow-up Miscellaneous Bibliography

Further Inpatient Care:

Further Outpatient Care:

In/Out Patient Meds:

Transfer:

Complications:

Prognosis:

Patient Education:

  MISCELLANEOUS Section 9 of 10   Click here to go to the previous section in this topic Click here to go to the top of this page Click here to go to the next section in this topic
Author Information Introduction Clinical Differentials Workup Treatment Medication Follow-up Miscellaneous Bibliography

Medical/Legal Pitfalls:

  • Failure to arrange proper follow-up care for patients with newly diagnosed breast mass
  • Failure to recognize need for drainage in patients with breast abscess
  BIBLIOGRAPHY Section 10 of 10   Click here to go to the previous section in this topic Click here to go to the top of this page
Author Information Introduction Clinical Differentials Workup Treatment Medication Follow-up Miscellaneous Bibliography

  • August DA, Sondak VK: Breast. In: Greenfield LJ, et al, eds. Surgery Scientific Principles and Practice, 2nd ed. Lippincott-Raven Publishers; 1997: 1357-1415.
  • Dener C, Inan A: Breast abscesses in lactating women. World J Surg 2003 Feb; 27(2): 130-3[Medline].
  • Dixon JM: Repeated aspiration of breast abscesses in lactating women. BMJ 1988 Dec 10; 297(6662): 1517-8[Medline].
  • Dixon JM: Outpatient treatment of non-lactational breast abscesses. Br J Surg 1992 Jan; 79(1): 56-7[Medline].
  • Eley JW, Hill HA, Chen VW, et al: Racial differences in survival from breast cancer. Results of the National Cancer Institute Black/White Cancer Survival Study. JAMA 1994 Sep 28; 272(12): 947-54[Medline].
  • Harris JR, Lippman ME, Veronesi U, and Willett W: Breast cancer (1). N Engl J Med 1992 Jul 30; 327(5): 319-28[Medline].
  • Karstrup S, Solvig J, Nolsoe CP, et al: Acute puerperal breast abscesses: US-guided drainage. Radiology 1993; 188: 807-9[Medline].
  • Khoda J, Lantsberg L, Yegev Y, and Sebbag G: Management of periareolar abscess and mamillary fistula. Surg Gynecol Obstet 1992 Oct; 175(4): 306-8[Medline].
  • Kitchen PR: Management of sub-areolar abscess and mammary fistula. Aust N Z J Surg 1991 Apr; 61(4): 313-5[Medline].
  • Maier WP, Au FC, Tang CK: Nonlactational breast infection. Am Surg 1994 Apr; 60(4): 247-50[Medline].
  • Meguid MM, Oler A, Numann PJ, Khan S: Pathogenesis-based treatment of recurring subareolar breast abscesses. Surgery 1995 Oct; 118(4): 775-82[Medline].
  • Miller BA, Feuer EJ, Hankey BF: The significance of the rising incidence of breast cancer in the United States. Important Adv Oncol 1994; 193-207[Medline].
  • O'Hara RJ, Dexter SP, Fox JN: Conservative management of infective mastitis and breast abscesses after ultrasonographic assessment. Br J Surg 1996 Oct; 83(10): 1413-4[Medline].
  • Walker AP, Edmiston CE, Krepel CJ, et al: A prospective study of the microflora of nonpuerperal breast abscess. Arch Surg 1988; 123: 908-11[Medline].
  • Watt-Boolsen S, Rasmussen NR, Blichert-Toft M: Primary periareolar abscess in the nonlactating breast: risk of recurrence. Am J Surg 1987 Jun; 153(6): 571-3[Medline].
  • Wiesenfeld HC, Sweet RL: Perinatal infections. In: Scott JR, et al, eds. Danforth's Obstetrics and Gynecology. 7th ed. Lippincott-Raven Publishers; 1994:469.

Breast Abscess and Masses excerpt